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Summary
A prominent 19kOa surface antigen of Legionella
pneumophila, cloned in Escherichia coli, was found to
be intimatety associated with peptidoglycan. The DNA
region encoding this antigen was mapped on an
11.9kb plasmid by means of detetion analysis and
transposon mutagenesis. PhoA' gene fusions, gene-
rated by JnphoA insertions into this region, confirmed
the presence of a gene encoding a secreted protein.
PhoA' transposon insertions were also associated
with loss of the 19 kDa antigen in immunoassays using
a monoclonal antibody (mAb1E9) and the replacement
of the 19kDa antigen with larger fusion proteins in
immunoblots using Legionella immune serum. A
1540bp Psfl fragment carrying the gene was
sequenced, and the open reading frame encoding the
antigen was identified. The gene encodes a potypep-
tide 176 amino acid residues long and 18913 Da in size.
The presence of a signal sequence of 22 amino acids
with a consensus sequence for cleavage by signal
peptidase II indicates that the antigen is a lipoprotein,
and striking similarity with peptidoglycan-associated
tipoproteins (PALs) from E. coli (51% amino acid
homoiogy) and Haemophilus influenzae (55% homo-
logy) is noted. We conclude that the 19kDa antigen of
L. pneumophila is the structural equivalent of the PAL
found in other Gram-negative species and suggest
that its post-translational acylation may explain its
potency as an immunogen.
Introduction
We previously described the cloning of a 19000Da
(19kDa) antigen of Legionella pneumophila and subse-
quently showed that this protein is accessible to serum
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antibodies on the surface of both L. pneumophila and
Escherichia coli clones carrying the gene for this antigen
on a multicopy plasmid, pSMJ11 (Engleberg et ai. 198-
4a,b). All L. pneumophila strains that vi/e have tested
express this antigen, and strains of several other
Legionella species express a smaller, cross-reactive pro-
tein of -18kDa (Engleberg e/a/., 1986). In polyacrylamide
gels, the 19kDa L pneumophila antigen nearly comigrates
with the E. coli peptidoglycan-associated lipoprotein
(PAL). Both the L. pneumophila protein and the comigrat-
ing E. ooli PAL produce a 'tailing' phenomenon in polya-
crylamide gels that is typically associated with Itpo-
proteins. Peptldogtycan-associated lipoproteins similar to
the £ coli PAL have been identified in several Gram-nega-
tive bacterial species (Mizuno, 1981; Delch et ai. 1990),
and we hypothesized that the 18-19 kDa Legionella
antigens might be homologues of these lipoproteins,
Although the functional role of the small, peptidoglycan-
associated lipoproteins remains unproven, it is assumed
that these molecules have a structural role, providing
anchorage between the cell wall and the outer membrane.
These molecules are of interest in pathogenic bacteria,
because they may be potent B-cell mitogens and
immunoadjuvants (Melchers etai. 1975; Lex etai, 1986).
Moreover, because they are primarily localized to the outer
membrane, they may be accessible to specific antibodies
on the bacterial surface. The Haemophilus influenzae PAL
has been shown to be a target for bactericidal antibodies
and may be regarded as a potential vaccine candidate
(Greene/a/., 1987).
In this communication we present the D̂ 4A sequence of
the 19 kDa L. pneumophila antigen gene. Its inferred
amino acid sequence data confirm the presence of a
signal for acylation and a high degree of amino acid
homoiogy with other known PAL sequences. We conclude
that this protein is a homologue of the previously
sequenced E. coli and H. mfluemae pal genes (Chen and
Henning, 1987; Deich etai. 1990).
Results
Peptidoglycan association of the 19kDa antigen
In a previous study, we showed that the L. pneumophila
major outer membrane protein (MOMP) is peptidoglycan-
bound by first heating bacteria in 2% sodium dodecyl
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Fig. 1. Immunoblots of sdi^ilized proteins from L pneumophila AA^OO.
identical immunoblots were probed with either L micdadei immune
serum (panel A) or mAbi E9 (panel B). L micdadei antiserum was used in
this experiment to minimize background and to limit the number of
visuaiized antigens. Immunoblots of bacteriai lysates with homologous
antisera produce a background reactivity wHh iipopolysacchande (LPS).
L micdade/antisefum has no detectable LPS cross-fBactlvity, but it has
strong cross-reactivity wtth the 19kDa antigen and several other L
pneumophila proteins, i-anes; a, supernatant from bacteria boiled in 2%
SDS for 2 min; b, insoluble pellet from lane a samples washed and
reboiled in 2% SDS for 5 min; c, insoluble pellet washed and reboiled in
4% SDS for 5 min.
sulphate (SDS) for 2 min, recovering the insoluble pellet by
centrifugation, and subsequently releasing the MOMP
from the pellet by reheating to 100°C for 10 min in 2% SDS
with 5% 2-mercaptoethanol (Engelberg et ai. 1989). In
that experiment, immunoblots of the peptidogiycan-asso-
ciated proteins with Legionella immune serum showed
that the predominant antigen released from the insoluble
pellet was 19 kDa in size. To confirm that this peptidogiy-
can-associated antigen is identical to the one encoded on
pSM J11, we repeated this experiment and immunobiotted
the peptidogiycan-associated fraction with immune sera
and with a monoolonal antibody (mAbi E9) that reacts with
the cloned antigen. The immunoblot shown in Fig. 1
confirms that much of the 19kDa antigen is associated
with peptidoglycan, since a significant proportion is
retained with the insoluble pellet after most other bacterial
proteins are solubilized. The reactivity of the antigen with
mAb1E9 in both soluble and insoluble fractions confirms
the identity of this protein.
Subcioning of the 19kDa antigen gene
The 19kDa antigen was originally cloned on plasmid
pSMJII (Engleberg et ai, 1984a). Various restriction
fragments were deleted from the insert in pSMJ11, and the
resulting clones were tested for expression of the 19 kDa
antigen (Fig. 2A). The ~3.75kb insert of pSMJ11.4 was the
smallest of the fragments that still expressed the antigen.
Either of two deletions within the pSMJ11.4 insert (made
at unique Sph I and Aval sites using S1 nuclease digestion
and blunt-end ligation) abrogated expression of the
19kDa antigen, suggesting that these mutations may
disrupt a reading frame that is critical for antigen
expression.
To be able, eventually, to mobilize the cloned gene from
E. coli into L. pneumophila. the insert expressing the
19kDa antigen was cloned into a vector with an antibiotic
resistance marker that is selectable in L. pneumophila. i.e.
pTLP5 (chloramphenicol-resistant. Cm"; streptomycin-
sensitive, Sm^). Accordingly, the EcoRI-Pvull fragment of
pSMJ11.4 was first ligated to pUCI 6 digested with EcoRI
and Smal. This manipulation allowed for the positioning of
the SamHI site of the pUC18 multiple cloning site next to
the PvuW-Sma I junction at which the insert and vector are
joined. The large SamHI-Sc/l fragment of this intermedi-
ate plasmid was then isolated and cloned into the unique
SamHI site of pTLP5 to yield pDH11.2. Immunoblotting
experiments confirmed that the 19kDa antigen Is
expressed from pDH11.2 to the same degree as from
pSMJ11.4 (data not shown).
Mutagenesis of a DNA fragment encoding the 19kDa
antigen with TnphoA
In Initial experiments with transpositional mutagenesis,
TnpAjOiA-1 was inserted into the fragment of interest on
pSMJ11.4. In later experiments, Tnp/io-4-onTwas inser-
ted into the slightly shorter fragment on pDH11.2. This
second set of transposon insertions was generated in
anticipation of future experiments (now in progress) in
which the mutated genes on these plasmids will be
transferred to L. pneumophila and exchanged for the
native genes. In all transposition experiments, E coli
CC118 carrying the relevant plasmid was infected with
either XTnp/ia4-1 or \::Jr\phoA-oriTand plated on LB/XP
media containing kanamycin (200 or 300|xg ml"'). Plas-
mid minlpreps were prepared from individual transduc-
tants that appeared blue (i.e. PhoA*̂ ) and were used to
retransform strain CC118. If the transconjugants were all
PhoA* on media with XP, then the plasmid was assumed
to have acquired a phosphatase function and was ana-
lysed using restriction endonucleases. Each transposition
yielding a PhoA fusion was designated by the letter B (for
'blue') followed by an individual number (given in Fig. 2B).
Several kanamycin-resistant transductants that were
PhoA" were likewise analysed to identify random inphoA-
oriT insertions in pDH11.2. These transpositions were
designated by the letter W (for 'white') followed by an
individual number.
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Fig. 2. Antfysto of pSUJ11 sutxionas •nd ttwlr
axpr«8Sk>n erf the 19kCta antigen.
A. Tha shaded veas of the linearized map
(abova) rapraaant the insert of L pneumophtia
ONA; tha unshaded portions represent falavant
sections of the vector, pBR322 The trianglaa
represent localized cfefetions made by
endonuclease digestion at the specified site, SI
nucteasa treatment, repair with Klenow Iraomaol.
afx] btunl-«nd Hge/Oon. Tha column at tha rtghl
a 19kDa antigan was laan on
Weslam biots ol the strains carrying tha
rBspacttva datatlon.
B. A raatrictlon map of the region cloned in
pSMJ11.4 and pOH11J2 is shown wtth tha
posKkxi of Tnp/xjA-orTT insertions below. The
direction of the phoA reading frame is Indicated
by an arrow over each transposition marker. For
reference purposes, the numerical deslgnatk)n for
each tranaposHion is given (see text concerning
nomandature). Note that the region from poaltion
600 to 12O0 IS entirely free of transpositions.
C. PolanUal open reading franwa daducad from
tha aaquanca of tha laiga Psf I fragmant ara
Indicatad by the open arrows below tha map.
Within the -3500bp insert of pSMJ11.4 and pDH11.2.
PhoA' gene fusions were limited to a -IBOObp region,
and all transpositions giving productive fusions were
oriented in the same direction (Fig. 2B). Several of these
transpositions were clustered near the Ava\ and SphI
sites, previously shown to be cntical for the expression of
the 19kDa antigen. Clones carrying transpositions B-16,
B-17, and all transpositions between, failed to react with
mAbi E9 by dot immunoblot analysis. In addition, Western
blot analysis of some of these clones using Legionella
immune serum shovi/ed that the 19 kDa antigen was
absent and that new antigenic bands of >47 kb, presuma-
bly fusion proteins, were present instead {Fig. 3, panel A).
Fusions downstream of B-17 did not affect expression of
the 19kDa antigen. We inferred from these findings that
the region defined by gene fusions B-16 to B-17
resents the gene encoding the 19 kDa antigen.
An additional cluster of PhoA* fusions was mapped to a
-lOOObp region immediately downstream from the
19kDa antigen gene (Fig. 2B). The clones carrying the
fusions from B-25 to B-28 were reactive with mAbi E9 and
all of those tested expressed the 19kDa antigen on
Western blots with Legionella immune serum. Western
blot analysis of several of these clones with alkaline
phosphatase antiserum showed fusion products of
increasing size (from ~69 to -88kDa) corresponding to
the point of the transposon insertion, i.e. as the trans-
poson insertions mapped further downstream, the fusion
products were larger (Fig. 3, panel B). This analysis
suggests that the cloned region immediately downstream
from the 19kDa antigen gene contains another gene
encoding a single secreted protein.
Rnally, 22 Jr\phoA-oriT transprasitions that did not
produce gene fusions were mapped within the pDH11.2
2024 N. C. Engleberg et al.






Flfl. 3. Immunoblots of strains earring TnphoA-
ooTgene fusions in the DNA fragment encoding
the 19kDa antigen.
A. Immunoblot virith L. pneumophila immune
aeaim. Lane a, E. coli control; lar>e b, E. coli
(pSMJ11.4); lanes c-g, TnptaA transpositions in
pSMJII.4, B-3, B-15, B-17, B-7. and B-11. Note
the weak reactivity of the rabbit serum with a
comigrating 19 kDa antigen in E. coli.
B. Immunoblot with alkallrw phosphatase
antiserum. Lane a, E. coli control; lane b, E. coli
(pDH11.2::B-55); lanes c-g, Tnp/iaA-cwT
transpositions in pDHI 1.2. B-70. B-2, B-52, 8-29.
and B-6. The mobilities of prastained molacular
weight markers are indicated. AP, native E. coli
alkaline phosphatase monomer.
insert fragment (Fig. 2B). These transpositions were
randomly distributed within the fragment, except for a
region of ~750bp immediately upstream of the 19kDa
antigen gene, into which no transpositions were isolated.
DNA sequence of the 19kDa protein antigen
The two Sphi-Pst\ fragments representing the upstream
and downstream portions of the 19 kDa antigen gene, as
well as a Sau3A fragment that spans the internal Sph I site,
were isolated and cloned into the replicative form of both
M13mp18 and M13mp19. Single-stranded templates of
the resulting phages were purified and sequenced as
described below. The first 140bp of sequence are derived
from a single strand and therefore should be considered
tentative. All remaining portions of the sequence were
derived from primer extension on both strands using
overlapping templates.
The DNA sequence obtained from these M13 subclones
is shown in Fig. 4. Three long open reading frames were
identified, all of which would be transcribed in the same
direction as the TnphoA gene fusions. One of the open
reading frames (528bp) spans the region to which the
19 kDa antigen gene was mapped (Fig. 2C). An upstream
open reading frame {orfU) of at least 309bp begins
upstream of the boundary of the sequenced fragment and
terminates 101 bp before the beginning of the 19kDa
gene. A downstream open reading frame {orfD) of at least
613bp begins 1 bp before the termination codon of the
19 kDa antigen gene (i.e. the sequence is . . . ATGA . . .}




1 CTGCACASTT CASGGTATTT TTATGCCGTC ACATCAAGTC CCTATAGTGR
51 AGAftGCAGAT TATCGATTCG ATACTCAACT An-GAAATTA GAGCAAAATT
101 TTATCAASAA ACCTAGTCTT CTTGAArrTT CAGCAAAAAT AGTACTAACC
151 CA17aTACTG ATAATCAAAT TATAGGCTCG CGAftTTGrrA GTTTACRAAT
201 MCTTGTTCA CAAGATACTC CrTATGGCGG AGTTATTGCG GCGAATCAGG
251 C a C C m C G ATTTACTGCA ACGGCAaCAG ACTTTGTTGT ATCGCATATT
301 AAACGTGATT AGGAATAGCC AAAAAATAAA AAGAATTGTA CAAr&JCTCT
351 CCATGATTAT CATCTGTAGT TTCTAAAAAA TAATAAGAAG AGTTT^f^A
401 ^'''"^•^G'^ T S A A G C C G G ATCGrTTTAT AAACTGGGK: TCCTTGTAGC
•151 AAGCGCTGTA TTGGTTGCAG CCTCmCTAfl AACCCCAGGC AGTGCGGATG
BDl GTGGGGCTGC GGTAGGTGAT GGTGATGCFA CTGCCCAAGG TTTGGGGCAA
551 ATGACTCACT TTGCrGGACA AGAGCCTGGG GAGTCCTATA CAACGCAGGC
601 ACCGCATAAT CAATTGTATT TGnTGCGTA TGftTGACAGC ACTTTGGCAT
651 CAAAATATTT ACCTTCTGTT fiACGCGCAf.G CAGAATATTr AAAGACTCAC
701 CCAGGTGCTC GAGTGATGAT AGCTGGACftT ACTTOATGAGC GTGGTAGCCG
751 TGfcATATAAC GTTGCTCrTG GTGAACGCCG TGCTGATACT GTAGCTGAAA
301 rrCTGCGTAT GGCAGGTGTT AGCAGACAAC AAATTCGAGT AGTIAGCTAC
8 51 GGCAAAGAGC GCCCCGCTAA TTATGGTCAT GRTCJUWTOT CGCATGCCCA
901 GAATCGACGC GTAGfcGTTTA T T T A T ^ ^ AACAAGATGA TTAATCGCAA
951 AAAATCCATT ATCACCCTAT GTTTTGTACT GATGCTTCCT TTCGCCTCAT
IQOl GGGCAGAAGC GCCAGTAATA GATGATAGTG AAAATTTTGC AATGATTGAC
1051 AGGCAAGAGG AGTATGATGC TCCCCTTGTC AATCCTAAGT ACGATAATCC
1101 TCAAATTGAG AGTGCTGAGT TOyiTGGGTC TCAAAATGAT AACTACTCAA
U51 CCGATACCTC TCAATCCTAT GATOWCCCG CACTTGTCAA AGAAGACCGA
1201 AGTACTATCA GTGACAATGC AAAGTTAATT GATAAAATTC AGCAGCTTCA
1251 AAAGGAAATA CAAGAGTTAC GTGGCCAGCT TGAAGTACAG GCACACGATT
1301 TGAAATTATT ACAGCAGCAG CAAGTCGCTT TCTACAAGGA TCTGGATTCT
1351 CGATTATCCA ATrCTTCAAC TTCAGCAAAA ACCATTCAAA ATGATAAACC
1401 AGCAACAGAT GTTTCATTGG GTTCTAATTC GCCAGCGACT TTAAAAGCAG
1451 CTTCTCCGCA AATCAAACGA GGGCCATCTA CAGGGCCATC TAATAGTAAA
1501 CCACAACCTG TTATTGCTGT TTCCAGGGCT AATCCTGCAG
Rg. 4. DNA sequence of 1540bp encoding the 19kDa antigen of L
prwumophila. The positions of the three targe open reading lran:>es are
indicated on the right, with arrows indrcating the initiatKin codons of pal
and orfD. Putative Shine-Dalgarno sequences associated with the
trartslational starts are indicated by boxes. These sequence data wid
appear in the EMBL/GenBank/DDBJ Nucleotide Sequence Data
Libraries under the accession number X60543.
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Fig, 5. Comparison of Ihe inferred amino acid
sequence of the L. pneumophila 19kDa antigen
with the E. coli and H. influenzae peptidogiycan-
associated lipoprotein {pal). Boxed areas indicate
regions of homoiogy allowing for conservative
substitutions. The arrow indicates the putative
cleavage site for signal peptidase 11.
The ATG codon that begins the 528 bp reading frame {at
nucleotide 410 in Fig. 4) is preceded by a consensus
Shine-Dalgamo sequence 8bp upstream, strongly sug-
gesting that this codon represents a translationai initiation
site (Stormo et ai, 1982). There is no obvious consensus
promoter sequence upstream of this initiation site (Mulli-
gan etai. 1964). The reading frame encodes a poiypeptide
of 176 amjno acid residues having a molecular weight of
18913Da.
Because our characterization of the 19 kDa antigen
suggested that it was peptidoglycan-bound and that it
might be a lipoprotein, we compared the inferred amino
acid sequence of this gene with that of the previously
sequenced E. coli and Haemophilus influenzae peptido-
glycan-bound lipoproteins (PALJ {Chen and Henning.
1987; Deioh et ai. 1990). With inclusion of conservative
substitutions, the comparison revealed 51 % and 55%
homoiogy between the 19 kDa antigen and the £ ooli and
H. influenzae pal gene products, respectively (Fig. 5). The
most striking similarity was observed in the carboxy-ter-
minal half of the proteins, which includes the peptidogly-
can-binding domain (66% and 6 1 % homoiogy. respec-
tively). All three sequences have putative signal
sequences terminating at a cysteine residue (at residue 22
in E. coli and L. pneumophila and at residue 20 in H.
influenzae). At these positions, there is also strong con-
formity with a consensus sequence for signal peptidase II
{Leu-Ala/Ser-Gly/Ala-Cys). which is found in about three-
quarters of all bacterial lipoproteins studied {Hayashi and
Wu. 1990). Both the E co// and L. pneumophila sequences
have conserative substitutions at the - 3 position;
however, Leu is strictly conserved at this position in only
75% of all sequenced lipoproteins. All three sequences
have Ser at position +2, a feature of 38% of all bacterial
lipoproteins {Hayashi and Wu, 1990). Given these striking
sequence similarities, we conclude that the 19 kDa antigen
of L. pneumophila is a homologue of the E. coli lipoprotein
and from now on we will refer to this L. pneumophila gene
as pai
Partial analysis of the genes flanking pal
It was apparent from the analysis of PhoA gene fusions
that the long open reading frame downstream of pal. orfD,
also encodes a secreted protein. orfD has several in-frame
methionine codons, but the only one preceded by a
possible Shine-Dalgarno sequence is the ATG codon that
overlaps with the termination codon of pal (at nucleotide
937). Using a partial amino acid sequence inferred from
orfD, we searched the protein data bank for similarities
with previously registered sequences. No extensive
homoiogy with a known protein sequence was uncovered.
A similar analysis of the other partial amino acid sequence
inferred from orfU also failed to yield any useful insights.
Eurther subcioning of the 19kDa protein antigen gene
Because the region upstream of pal was devoid of
transpositions from a point approximately 400bp
upstream from the 5' end of our sequenced region to the
3' end of orfU (Fig. 2), we speculated that orfU may be an
essential gene when pal and/or the downstream genes are
cloned in multiple copies. If so, orfU might encode either a
transoriptional repressor of pal {and other downstream
genes) or a protein that interacts post-translationally with
the products of pal and/or other genes to assure their
appropriate expression. All the subclones we had
generated, including the M13 derivatives prepared for
sequencing, carried either fragments of pal or an intact
copy of pal with the transpositional ly silent, upstream
region.
To determine whether pal could be expressed indepen-
dently of orfU, we attempted to subcione the 1333bp
Pst\-Xho\\ fragment of pDH11.2 that carries the entire pal
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gene and the 3' end of orfU(Fig. 2B) by ligating it into the
pBR322 derivative, pJAI, afier digestion with BamHl and
Nsi\. After several attempts to do this had failed, we
repeated the ligation reaction and then transformed
competent £ co/zHBIOI and HB101{pDH11.2::Tnpha4-
onT.B-16) in parallel. Phenotypically, the latter strain is
Km" (kanamycin-resistant). Cm", PhoA" ,̂ and PAL . and
the plasmid (which we will abbreviate in further references
as 'pDH11.2::B-16') includes an intact orfU region. As
expected, there were no ampicillin-resistant {Ap'') trans-
fonmants of HB101: however, using the same amount of
the same ligation mixture, there were 53 Ap" trans-
formants of HB101{pDH11.2::B-16), two of which were
also PAL*. One of the PAL* isolates contained two
ptasmids: one was the size of pDH11.2::B-16, and the
other was the size predicted for the pJAI-pa/ hybrid
plasmid. When this isolate was passed on streptomycin-
containing media to counterselect pDH11.2::B-16 (which
carries rpsL (Sm^ allele), 30 colonies were screened and
found to be Cm^, Km", and Ap"; all 30 were PAL'. The
original PAL* isolate and the Sm" isolates were unstable
and became PAL with passage, in spite of continued
selective pressure with ampicillin, and they lost all detect-
able plasmid DNA. The second of the two PAL* trans-
formants carried a single plasmid intermediate in size
between pDH11.2::B-16 and the pJAI-pa/hybrid. Strep-
tomycin-resistant derivatives from this isolate were Cm®,
Km^. Ap", and PAL*. This isolate and its derivatives were
also highly unstable with respect to PAL reactivity and
continued presence of plasmid DNA.
Discussion
These studies demonstrate that the 19kDa surface
antigen is the peptidogiycan-associated lipoprotein of L.
pneumophila. The label 'peptidogiycan-associated lipo-
protein' was first applied to certain matrix proteins of
Pseudomonas aeruginosa and f . coli (Mizuno. 1979).
These molecules were characterized by their retention on
the cell wall in 2% SDS at 35*'C. by labelling with
[^^C]-palmitic acid and 2-[^H]-glycerol, and by bio-
chemical separation from the covalently bound murein-
lipoprotein described by Braun {Mizuno, 1979; Braun.
1975). Subsequently, similar lipoproteins were found in
Proteus mirabilis and a wide variety of Gram-negative
organisms {Mizuno, 1981). Even before DNA sequencing,
we suspected that this was also the identify of the L
pneumophila 19kDa antigen because of its comigration of
the £ coli PAL, the non-covalent but strong association
with the cell wall, and the tailing phenomenon associated
with this protein band in Western blots.
DNA sequencing was directed at a small region of the
cloned insert of pSMJl i that had been identified as the
gene encoding the antigen by deletion analysis and
transposon mutagenesis. The isolation of PhoA* fusions
within this gene again confimed that its product is a
secreted polypeptide. An open reading frame, beginning
with a consensus initiation codon, was found in the
appropriate map position and correct orientation.
The sequence of the putative open reading frame
encodes a protein with extensive homoiogy to the pal
genes of both E coli and H. influenzae. The degree of
homoiogy is roughly comparable between any of the three
sequences, particularly in the C-terminal half of the protein
that is known to include the peptidoglycan-binding
domain (Mizuno et ai. 1982). In addition, the L pneumo-
phila protein t>egins with a signal sequence of 22 residues
that ends with a consensus cleavage site for signal
peptidase II. The presence of these features in an amino
acid sequence has been generally considered sufficient
evidence to characterize the sequence as a lipoprotein
(Hayashi and Wu, 1990). This finding, combined with the
physical characteristics of the protein and the sequence
homology. leave no doubt as to its identity as the L.
pneumophila PAL.
PAL is one of the most potent immunogens of L
pneumophila. Its prominence as an antigen probably
explains why it was so readily cloned in our early experi-
ments and in experiments by others who also screened an
£ CO//genomic library with Legionella immune serum. The
reason for its immunogenicity may relate to its lipoprotei-
naceous nature. The Braun lipoprotein has long been
known to be a B-cell mitogen (Melohers et ai. 1975), and
its mitogenicity can be reproduced by various synthetic
lipopeptides that mimic its A/-terminus (Wiesmuller ef al.,
1983). The synthetic analogues differ from lipoprotein
W-temiini only in that their lipid components are uniformly
composed of palmitic acid. The tripalmitoyi dipeptide
/S^palmitoyl-S- (2,3-bis(palmitoyloxy) - (2RS) -propyO-(fl)-
cysteine-serine (or Pamg-Cys-Ser) is as potent a poly-
clonal B-cell activator as longer lipopeptide analogues
(Prass et ai. 1987). This is noteworthy since this lipropep-
tide may also mimic the A/-terminus of the L. pneumophila
PAL.
In addition to their mitogenicity, synthetic lipopeptide
analogues have also been shown to act as potent
immunoadjuvants {Lex et ai. 1986). A significant adjuvant
effect was recently demonstrated for the lipotripeptide
Pam3-Cys-Ser-Lys-, covalently bound to the hapten.
dinitrophenol (Reitermann et ai, 1989). Again, this ana-
logue mimics the L. pneumophila PAL sequence. Similar
synthetic analogues have been shown to activate macro-
phages and to induce the production of IL-1, IL-6. and
TNFa {Hauschildt etai, 1990).
The implications of these lipoprotein properties for
bacterial infections are speculative. However, immuno-
genic surface proteins from a variety of pathogenic
bacteria are now known to be lipoproteins. These include
the H.8 outer membrane protein of the pathogenic
Legionella pneumophila lipoprotein antigen 2027
Neisseria species (Cannon, 1989), the P6 protein (or PALj
of H. influenzae (Murphy et ai, 1986). the Braun lipoprotein
analogue of Brucella abortus (Gomez-Miguel et ai, 1988),
OspA and OspB of Borrelia burgdorferi{Bergstrom etai.
1989). and the 34kDa membrane protein of Treponema
pallidum (Swancutt et ai, 1990). The H. influenzae PAL has
been shown to be a target for bactericidal antibody, even
in type b encapsulated strains (Green et ai, 1987). This
conserved molecule is therefore a potential vaccine candi-
date. Likewise, monoclonal antibodies directed against
this PAL have been useful in non-culture diagnostic
methods for H. influenzae {Groeneveld ef ai, 1989).
Whether or not the L. pneumophila PAL will prove similarly
useful for preventive or diagnostic use against
Legionnaires' disease is open to investigation.
The upstream partial open reading frame, which we
have temporarily designated as orfU. seems to be required
for the maintenance of pal in multiple copies. We were
never able to isolate a transposition into this gene on a
plasmid that contains pal, and we were never successful in
cloning pal apart from orfU. We succeeded in isolating
orfU and pal to separate replicons in the same strain;
however, these constructs were exceedingly unstable. We
speculate that £ coli may not tolerate multiple, isolated
copies of pal and that the orfU region may exert a
necessary moderating effect, e.g. by encoding a negative
transcriptional regulator or a protein that effects PAL at the
post-translational level. Transcriptional analysis of pal will
resolve this issue.
It is unknown whether PAL has a role in the pathogene-
sis of Legionnaires' disease. As a possible mitogen and
immunoadjuvant. it may influence disease by modulating
the immune response. Alternatively, certain bacterial
membrane lipoproteins, e.g. TraT, have been found to
interfere with complement deposition, increase bacterial
serum resistance, and marginally improve the growth of
Salmonella typhimurium in a mouse model of infection
{Rhen and Sukupolvi, 1988). More recently, genes encod-
ing membrane iipoproteins that confer serum resistance in
Vibrio choterae were found to be activated by the global
regulator of virulence in that species (ToxR; Parsot e( a/.,
1991). Whether or not PAL participates in serum resist-
ance of L pneumophila or in other aspects of virulence is
entirely speculative, but these questions might be
addressed by generating isogenic pat~ mutants or by
manipulating the expression of PAL in L. pneumophila. In
this study, several transferable plasmids were constructed
with insertion mutations in pat or orfD that can be used for
allelio exchange experiments in L. pneumophila.
Experimental procedures
Bacterial and plasmids
L. prieumophila AA^ 00 is a clinical Isolate that retains a high level
of virulence for cultured macrophages and guinea-pigs. L
pneumophila AA103 is a nalidixic acid- and streptomycin-resis-
tant derivative of AA100. L pneumophila strains were grown on
buffered charcoal yeast extract agar supplemented with a-keto-
glutarate (BCYE-a) (Edelstein. 1982).
E. coli LE392 (supE. supF) was used to propagate
bacteriophage K 431 {6221. cl857, Pam) carrying either inphoA
(i.e. KTnphoA-1) or JnphoA-onT.RecA~ Eco/;strainsHB101 and
CC118 were used for most cloning experiments. CC118 has
deietion p/7oAA20 {Manoll and Beckwith, 1985). dam E. coli
strain K3216 (obtained from D. Friedman, University of Michigan)
was used to propagate plasmids prior to performing BcH
digestions.
pSMJ11 is a derivative of pBR322 that has a 7.5kb fragment
from L pneumophila AA100 cloned in the SamHi site. pJA1 is a
derivative of pBR322 that carries a unique multiple cloning site
and which was designed and constructed in this laboratory.
pTLP5 was also constructed in this laboratory (by J.A.) for the
purpose of gene transfer to L. pneumophila. This plasmid carries
the same multiple cloning site as pJA1. Further details of its
construction will be reported elsewhere; however, for the pur-
poses of this study, it is necessary to know that pTLP5 carries the
chloramphenicol acetyltransferase gene of pACYC184, which is
selectable in L pneumophila, and the E. coli rpsL allele, which
confers streptomycin sensitivity In L. pneumophila strain AA103.
JnphoA-onTwas generated by insertion of an origin of transfer
from the IncP group of conjugative plasmids into the SamHI site
of Tnp/joA {Manoil and Beckwith. 1985); this insertion inactivates
the cryptic Sm'^ gene of JnphoA. Details of this construction will
be presented elsewhere (J. Arroyo, in preparation). PhoA fusions
were screened by growing colonies on LB media with 40 jig m i " '
of 5-bromo-4-choro-3-indolyl phosphate p(P).
Antibodies and sera
Rabbit antisera were prepared by subcutaneous injection with
heat-killed L pneumophila or L micdadei at biweekly intervals for
6 weeks. Anti-alkaline phosphatase senjm was prepared by
injection of £ co//alkaline phosphatase {Sigma Chemical Co.) in
complete Freund's adjuvant initially and in incomplete Freund's
adjuvant for booster immunizations.
Monocional antibody 1E9 is a mouse monoclonal antibody
generated by immunization with crude outer membrane fractions
of L. pneumophila. To avoid production of antibodies to lipopoly-
saccharide. fractions for booster immunizations were isolated
from L pneumophila of diverse serogroups. Reactivity of mAb-
1E9 with the native and cloned PAL antigen from AA100 was
confirmed by immunoblotting; mAbi E9 also reacts with a 19kDa
antigen in other L. pneumophila strains representing serogroups
1-8, but has no reactivity with any proteins of L micdadei or E.
coli. by immunoblot analysis or dot immunoassay of whole
bacteria.
Gel electrophoresis and immunoblotting
Bacterial pellets were lysed and proteins were solubilized by
boiling in 2% SDS. 5% 2-mercaptoethanol. 50mM Tris-HCI (pH
6.8) for 2-5 min in different experiments. Insoluble material was
removed by centrifugation at 12000 x gfor 5 min before loading
of samples. In experiments requiring re-extraction of the cell-wall
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material, the insoluble pellet was washed once in water, then
re-extracted as described.
SDS lysates were separated by polyacrylamide gel elec-
trophoresis (Laemmli. 1970). Proteins were electrotransferred to
nitrocellulose membranes over 3 h at 40 volts in Tris-glycine buffer
with 20% methanol (pH 8.3). Enzyme immunoassays were
performed on blots in 50 mM Tris-buffered saline {pH 7.5) with
0.05% Tween-20 (T-TBS). T-TBS was made with 500 mM NaCI
for assays with immune serum and at 150 mM NaCI for assay with
mAb1E9. After one hour of blocking in T-TBS. diluted immune
sera or neat mAb1E9 hybridoma supematants were incubated
with blots overnight. After three washes in T-TBS. blots were then
incubated for one hour in horseradish peroxidase-conjugated
goat anti-rabbit or anti-mouse immunoglobulins (Cappel Labora-
tories). After three final washes, peroxidase activity was detected
using 0.06% diamlnobenzidine {Sigma Chemical Co.) in 0.003%
hydrogen peroxide.
Subcioning
Plasmid DNA was isolated by the alkaline lysis method (Bimboim
and Doly. 1979). Restriction fragments for subcioning were
isolated from agarose gels by electrophoresis onto DEAE mem-
brane {Schleicher & Schuell) and eluted into high-salt buffer as
described {Uzardi et ai. 1984). Ligation and transformation of
CaCb-treated E coli were performed using standard methods
{Sambrook otal., 1989).
Transposon mutagenesis
£ cxjii strains carrying plasmids with target sequences were
transduced to kanamycin resistance with kJnphoA-^ or
K::TnphQA-oriT. Plasmids were then isolated and introduced into
CC118 by transformation or were transferred conjugally (in the
case of Tnp/ja4-ori71 using a helper strain with conjugative
plasmid pRK212.1. If transpositions mapped to the plasmid, the
plasmid was isolated by the alkaline lysis technique, and the
position of the transposon was mapped with restriction endo-
nucleasas.
DW4 sequencing
Sequencing of M13 templates was performed using the dideoxy
chain termination method (Sanger et ai. 1977). M13-based
primers were used initially, but for subsequent reactions, oligo-
nudeotide primers were synthesized. Primer extension was
catalysed by Sequenase {US Biochemical). DNA and protein
sequences were analysed using Microgenie and MacVector
software. Searches of the National Library of Medicine Protein
Data Bank were supported by both of these software packages.
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